Market Overview

Top 4 Small-Cap Stocks In The Drug Manufacturers-Major Industry With The Highest Revenue

Below are the top small-cap drug manufacturers-major stocks on the NYSE, the NASDAQ and the NASDAQ in terms of revenue.

The trailing-twelve-month revenue at Impax Laboratories Inc (NASDAQ: IPXL) is $453.46 million. IPXL had $359.80 million in total cash for the latest quarter.

The trailing-twelve-month revenue at WuXi PharmaTech (Cayman) Inc (NYSE: WX) is $387.21 million. WX's ROE for the same period is 17.74%.

The trailing-twelve-month revenue at China Pharma Holdings Inc (AMEX: CPHI) is $82.68 million. CPHI's operating margin for the same period is 27.43%.

The trailing-twelve-month revenue at Astex Pharmaceuticals Inc (NASDAQ: ASTX) is $60.99 million. ASTX had $125.69 million in total cash for the latest quarter.

Posted-In: Drug Manufacturers-Major Industry Highest Revenue small-capTrading Ideas

 

Related Articles (IPXL + CPHI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters